Search Prime Grants

W81XWH2210635

Project Grant

Overview

Grant Description
Po versus IV antibiotics for the treatment of infected nonunion of fractures after fixation.
Awardee
Vanderbilt University Medical Center
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Nashville, Tennessee 372320011 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $2,249,987 to $0.
Vanderbilt University Medical Center was awarded Project Grant W81XWH2210635 from Defense Health Agency in September 2022 with work to be completed primarily in Nashville Tennessee United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 1/17/24

Period of Performance
9/30/22
Start Date
9/29/26
End Date
39.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Subgrant Awards

Disclosed subgrants for W81XWH2210635

Transaction History

Modifications to W81XWH2210635

Additional Detail

Award ID FAIN
W81XWH2210635
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
GYLUH9UXHDX5
Awardee CAGE
7HUA5
Performance District
TN-07
Senators
Marsha Blackburn
Bill Hagerty

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $2,249,987 100%
Modified: 1/17/24